List of works - Gianluca Petris

A highly specific SpCas9 variant is identified by in vivo screening in yeast

scientific article published on 29 January 2018

Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

scientific article published on 07 August 2019

Author Correction: Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

scientific article published on 22 October 2020

BiP/GRP78 Mediates ERAD Targeting of Proteins Produced by Membrane-Bound Ribosomes Stalled at the STOP-Codon

scientific article published on 24 October 2018

CD4 and BST-2/tetherin proteins retro-translocate from endoplasmic reticulum to cytosol as partially folded and multimeric molecules

scientific article

Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors

scientific article published on 07 December 2020

Efficient detection of proteins retro-translocated from the ER to the cytosol by in vivo biotinylation.

scientific article

Engineered tobacco etch virus (TEV) protease active in the secretory pathway of mammalian cells

scientific article published on 29 August 2015

Hit and go CAS9 delivered through a lentiviral based self-limiting circuit

scientific article published on 22 May 2017

Inherited determinants of early recurrent somatic mutations in prostate cancer.

scientific article

Mechanism-based traps enable protease and hydrolase substrate discovery

scientific article published on 16 February 2022

New tags for recombinant protein detection and O-glycosylation reporters

scientific article

Pharmacological inactivation of the prion protein by targeting a folding intermediate

scientific article published on 12 January 2021

Refactored genetic codes enable bidirectional genetic isolation

scientific article published on 4 November 2022

Selective targeting of proteins within secretory pathway for endoplasmic reticulum-associated degradation.

scientific article

The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD)

scientific article

Tobacco Etch Virus protease: A shortcut across biotechnologies.

scientific article published on 13 June 2016

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.

scientific article published on 11 July 2018

List of works by Gianluca Petris

A highly specific SpCas9 variant is identified by in vivo screening in yeast

Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

Author Correction: Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

BiP/GRP78 Mediates ERAD Targeting of Proteins Produced by Membrane-Bound Ribosomes Stalled at the STOP-Codon

CD4 and BST-2/tetherin proteins retro-translocate from endoplasmic reticulum to cytosol as partially folded and multimeric molecules

Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors

Efficient detection of proteins retro-translocated from the ER to the cytosol by in vivo biotinylation.

Engineered tobacco etch virus (TEV) protease active in the secretory pathway of mammalian cells

Hit and go CAS9 delivered through a lentiviral based self-limiting circuit

Inherited determinants of early recurrent somatic mutations in prostate cancer.

Mechanism-based traps enable protease and hydrolase substrate discovery

New tags for recombinant protein detection and O-glycosylation reporters

Pharmacological inactivation of the prion protein by targeting a folding intermediate

Refactored genetic codes enable bidirectional genetic isolation

Selective targeting of proteins within secretory pathway for endoplasmic reticulum-associated degradation.

The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD)

Tobacco Etch Virus protease: A shortcut across biotechnologies.

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.